Alise Reicin, CEO of Tectonic Therapeutic ($TECX), bought shares on the open market twice in the past year for a total of $105,500. Her most recent purchase was on February 11, 2026. These buys rank her 2,092nd among nearly 5,000 insiders, well below the average of $1.5 million across 3.3 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 69250 | $0.00 | 69,250.0000 | 18,716,280 | 9999.99% | 0.37% |
| Feb. 11, 2026 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | P | Common Stock | 2500 | $21.10 | 362,077.0000 | 18,716,280 | 0.70% | 0.01% |
| March 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Common Stock | 76500 | $0.00 | 438,577.0000 | 18,716,280 | 21.13% | 0.41% |
| Feb. 11, 2026 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | P | Common Stock | 2500 | $21.10 | 362,077.0000 | 18,716,280 | 0.70% | 0.01% |
| Feb. 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | F | Common Stock | 4104 | $23.22 | 359,577.0000 | 18,716,280 | 1.13% | 0.02% |
| Dec. 31, 2025 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | M | Common Stock | 10966 | $2.38 | 363,681.0000 | 18,716,280 | 3.11% | 0.06% |
| Dec. 31, 2025 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | M | Employee Stock Option (Right to Buy) | 10966 | $0.00 | 22,957.0000 | 18,716,280 | 32.33% | 0.06% |
| Sept. 25, 2025 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Common Stock | 14700 | $0.00 | 352,715.0000 | 18,662,672 | 4.35% | 0.08% |
| Sept. 25, 2025 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 26710 | $0.00 | 26,710.0000 | 18,662,672 | 9999.99% | 0.14% |
| June 20, 2025 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | F | Common Stock | 859 | $19.81 | 338,015.0000 | 18,662,672 | 0.25% | 0.00% |
| June 5, 2025 | Sana Biotechnology, Inc. | $SANA | REICIN ALISE | Not found | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 225,024,899 | 9999.99% | 0.04% |
| Feb. 4, 2025 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 101953 | $0.00 | 101,953.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2025 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Common Stock | 36047 | $0.00 | 338,874.0000 | 0 | 11.90% | 0.00% |
| Dec. 4, 2024 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Common Stock | 11717 | $0.00 | 302,827.0000 | 0 | 4.02% | 0.00% |
| Dec. 4, 2024 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Sana Biotechnology, Inc. | $SANA | REICIN ALISE | Not found | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 23380 | $0.00 | 23,380.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 33923 | $0.00 | 33,923.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Common Stock | 124530 | $0.00 | 291,110.0000 | 0 | 74.76% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Common Stock | 166580 | $0.00 | 291,110.0000 | 0 | 133.77% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | REICIN ALISE | Chief Executive Officer | A | Employee Stock Option (Right to Buy) | 289600 | $0.00 | 289,600.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Sana Biotechnology, Inc. | $SANA | REICIN ALISE | Not found | A | Stock Option (Right to Buy) | 54278 | $0.00 | 54,278.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Q32 Bio Inc. | $QTTB | REICIN ALISE | Not found | A | Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 0 | 9999.99% | 0.00% |